Life Science Company News

Reset
Results 41 - 60 out of 500 displayed.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Rentschler Biopharma SE | Rentschler Biopharma Inc. | Rentschler Biopharma Inc.

Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Milestone Pharmaceuticals Inc.

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Akoya Biosciences, Inc.

Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Taysha Gene Therapies, Inc.

NewAmsterdam Pharma to Host R&D Day with Key Opinion Leaders on May 16, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  NewAmsterdam Pharma B.V.

Mineralys Therapeutics to Announce First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 9, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Mineralys Therapeutics, Inc.

Protara Therapeutics Announces First Quarter 2024 Financial Results and Provides Business Update

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Protara Therapeutics, Inc.

Positive Initial Clinical Data Reported from Immutep’s Efti Combined with Radiotherapy and Checkpoint Inhibitor from Phase II Trial in Soft Tissue Sarcoma

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Immutep Limited

Amolyt Pharma Granted FDA Fast Track Designation for Eneboparatide for the Treatment of Hypoparathyroidism

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Amolyt Pharma SAS

Daré Bioscience Selected as a Member of ARPA-H Investor Catalyst Hub Spoke Network

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Daré Bioscience, Inc.

Lisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Lisata Therapeutics, Inc.

LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  LifeMD, Inc

The Canadian Dermatology Association (CDA) Announces the Launch of the 2024 Shade Structure Grant Program

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Canadian Dermatology Association

iCAD to Report First Quarter 2024 Financial Results on May 15, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  iCAD, Inc.

Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Science 37, Inc.

Shape Therapeutics Announces Appointment of Matt Valentino as Chief People Officer

Read more ››
By: GlobeNewswire - 02 May 2024

PDS Biotech Appoints Stephan Toutain as Chief Operating Officer

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  PDS Biotechnology Corporation

Intuity Medical’s POGO Automatic®, the First and Only FDA-Cleared Automatic Blood Glucose Monitor, Now Covered by Medicare Part B

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Intuity Medical, Inc

EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  EDAP TMS S.A.

Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer

Read more ››
By: GlobeNewswire - 02 May 2024
Related companies:  Allarity Therapeutics, Inc.
Results 41 - 60 out of 500 displayed.
«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »